Single-use by design: why reusability should not be the regulatory default under MDR Article 17

As discussions on the revision of the EU Medical Devices Regulation (MDR) continue, the conditions governing the reuse of medical devices remain an important issue for healthcare providers, patients and the medical technology sector.

Our new paper examines the proposed changes to MDR Article 17 and provides an overview of the key considerations surrounding the reuse and reprocessing of single-use medical devices, including the implications of making reuse the regulatory default.

The paper sets out MedTech Europe’s perspective on how the regulatory framework can:

• Support safe and appropriate reprocessing
• Maintain a high level of patient safety
• Ensure a clear, workable and science- and risk-based regulatory approach.

Read the full paper to explore MedTech Europe’s recommendations for the revision of MDR Article 17.